Page 1 of 3
123

2025 (3 POSTS)

Rogers JM, Heintz MM, Haws LC. 2025. Reproductive and developmental toxicity screen (OECD TG 421) and extended one generation reproductive toxicity study (OECD TG 443) of decahydronaphthalene in Sprague Dawley rats. Regul Toxicol Pharmacol 105829; doi: 10.1016/j.yrtph.2025.105829. Online ahead of print 11 April 2025. PMID: 40222475.

View Abstract

Rogers JM, Heintz MM, Haws LC. Reproduction/developmental toxicity screen and extended one generation reproductive toxicity study of decahydronaphthalene in Sprague Dawley rats. Abstract 3864, Society of Toxicology 64th Annual Meeting, Orlando, FL, March 2025.

View Abstract

Rogers JM, Buerger AN, Heintz MM, Palermo CM, Haws LC, Lea IA. 2025. Evaluation of a hypothesized Sertoli cell-based adverse outcome pathway for effects of diisononyl phthalate on the developing testis. Curr Res Toxicol 8:100219; doi: 10.1016/j.crtox.2025.100219. PMID: 40123861.

View Abstract

2023 (2 POSTS)

Henderson RG, Welsh BT, Rogers JM, Borghoff SJ, Trexler KR, Bonn-Miller MO, Lefever TW. 2023. Reproductive and developmental toxicity evaluation of cannabidiol. Food Chem Toxicol 176(June):113786; doi: 10.1016/j.fct.2023.113786. PMID: 37105390.

View Abstract

Rogers JM, Heintz MM, Thompson CM, Haws LC. 2023. A putative adverse outcome network for neonatal mortality and lower birth weight in rodents: Applicability to per- and polyfluoroalkyl substances and relevance to human health. Birth Defects Res 115(11)1011-1062; doi: 10.1002/bdr2.2185. PMID: 37219003.

View Abstract

2022 (2 POSTS)

Rogers JM, Heintz MM, Thompson CM, Haws LC. Development of a putative adverse outcome pathway for neonatal mortality in rodents: Implications for human health risk assessments of PFAS. Poster presented at Society of Toxicology 61st Annual Meeting, San Diego, CA, March 2022.

View Abstract

Heintz MM, Chappell GA, Thompson CM, Wolf JC, Rogers JM, Haws LC. HFPO-DA (GenX) transcriptomic responses in pregnant and non-pregnant rat livers: Analyses to inform the role of maternal effects on neonatal toxicity. Poster presented at Society of Toxicology 61st Annual Meeting, San Diego, CA, March 2022.

View Abstract

2020 (1 POST)

Watanabe M, Rogers JM. 2020. Introduction to “The Trouble with Plastics” special issue. Birth Defects Res 112(17):1297–1299; doi: 10.1002/bdr2.1795.

View Abstract

2019 (3 POSTS)

Zucker RM, Rogers JM. 2019. Confocal laser scanning microscopy of morphology and apoptosis in organogenesis-stage mouse embryos. Meth Mol Biol 1965:297–311; doi: 10.1007/978-1-4939-9182-2_20.

View Abstract

Rogers JM, Watanabe M. 2019. Editorial: Special issue on “Developmental effects of smoking, vaping, and cannabis use.” Birth Defects Res 111(17):1245–1247; doi: 10.1002/bdr2.1596.

View Abstract

Rogers JM. 2019. Smoking and pregnancy: Epigenetics and the developmental origins of the metabolic syndrome. Birth Defects Res 111(17):1259–1269; doi: 10.1002/bdr2.1550.

View Abstract

2014 (3 POSTS)

Beasley TE, Evansky PA, Martin SA, McDaniel KL, Moser VC, Luebke RW, Norwood J Jr, Rogers JM, Copeland C, Bushnell PJ. 2014. Toxicological outcomes in rats exposed to inhaled ethanol during gestation. Neurotoxicol Teratol 45(Sept-Oct):59–69; doi: 10.1016/j.ntt.2014.07.002.

View Abstract

Daston GP, Beyer BK, Carney EW, Chapin RE, Friedman JM, Piersma AH, Rogers JM, Scialli AR. 2014. Exposure-based validation list for developmental toxicity screening assays. Birth Defects Res B 101(6):423–428; doi: 10.1002/bdrb.21132.

View Abstract

Rogers JM, RE Ellis-Hutchings, BE Grey, RM Zucker, J Norwood, Jr., CE Grace, C Gordon, C Lau. 2014. Elevated blood pressure in offspring of rats exposed to diverse chemicals during pregnancy. Toxicol Sci 137(2):436–446; doi: 10.1093/toxsci/kft248.

View Abstract

2013 (1 POST)

Urban JD, Thompson CM, Deskin R, Waite M, Haws LC. 2013. Development of an oral cancer slope factor for acrylamide based on tumors relevant to humans. Presented at Society of Toxicology 52nd Annual Meeting, San Antonio, TX, March 2013.

View Abstract

2012 (2 POSTS)

Boekelheide K, Blumberg B, Chapin RE, Cote I, Graziano JH, Janesick A, Lane R, Lilycrop K, Myatt L, States JC, Thayer KA, Waalkes MP, Rogers JM. 2012. Predicting later-life outcomes of early-life exposures. Environ Health Perspect 120:1353–1361; doi: 10.1289/ehp.1204934.

View Abstract

Schugg TT, Erlebacher A, Leibowitz S, Ma L, Muglio LJ, Rando OJ, Rogers JM, Romero R, von Saal FS, Wise LD. 2012. Fetal programming and environmental exposures: Implications for prenatal care and preterm birth. Ann NY Acad Sci 1276(1):37–46; doi: 10.1111/nyas.12003.

View Abstract

2011 (3 POSTS)

Beyer BK, Chernoff N, Danielsson BR, Davis K -Bruno, Harrouk W, Hood RD, Janer G, Wändel Liminga U, Kim J, Rocca M, Rogers JM, Scialli AR. 2011. Maternal toxicity and its impact on study design and data interpretation. Birth Defects Res B 92(1):36–51; doi: 10.1002/bdrb.20281.

View Abstract

Grace CE, Kim SJ, Rogers JM. 2011. Maternal influences on epigenetic programming of the developing hypothalamic-pituitary-adrenal axis. Birth Defects Res A 91:797–805; doi: 10.1002/bdra.20824.

View Abstract

Lau C, Rogers JM, Desai M, Ross MG. 2011. Fetal programming of adult disease: Implications for prenatal care. Obstet Gynecol 117(4):978–985; doi: 10.1097/AOG.0b013e318212140e.

View Abstract
Page 1 of 3
123